Search

Nicole Erin Kinsey White

Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1130
Issued Applications
560
Pending Applications
136
Abandoned Applications
472

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 379919 [patent_doc_number] => 07309490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => 'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response' [patent_app_type] => utility [patent_app_number] => 11/198323 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6768 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309490.pdf [firstpage_image] =>[orig_patent_app_number] => 11198323 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198323
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response Aug 7, 2005 Issued
Array ( [id] => 5520905 [patent_doc_number] => 20090028886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Carrier conjugates of gnrh-peptides' [patent_app_type] => utility [patent_app_number] => 11/659221 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27569 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028886.pdf [firstpage_image] =>[orig_patent_app_number] => 11659221 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/659221
Carrier conjugates of gnrh-peptides Aug 3, 2005 Abandoned
Array ( [id] => 5246969 [patent_doc_number] => 20070243203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Vaccine for Prevention and Treatment of Hiv-Infection' [patent_app_type] => utility [patent_app_number] => 11/573128 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14796 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243203.pdf [firstpage_image] =>[orig_patent_app_number] => 11573128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/573128
Vaccine for prevention and treatment of HIV-infection Aug 2, 2005 Issued
Array ( [id] => 5880533 [patent_doc_number] => 20060029615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Novel recombinant T4 phage particle and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/188236 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14802 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029615.pdf [firstpage_image] =>[orig_patent_app_number] => 11188236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/188236
Novel recombinant T4 phage particle and uses thereof Jul 21, 2005 Abandoned
Array ( [id] => 5434917 [patent_doc_number] => 20090169503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'DNA-BASED VACCINATION OF RETROVIRAL-INFECTED INDIVIDUALS UNDERGOING TREATMENT' [patent_app_type] => utility [patent_app_number] => 11/571879 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25392 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169503.pdf [firstpage_image] =>[orig_patent_app_number] => 11571879 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/571879
DNA-BASED VACCINATION OF RETROVIRAL-INFECTED INDIVIDUALS UNDERGOING TREATMENT Jul 10, 2005 Abandoned
Array ( [id] => 6220574 [patent_doc_number] => 20100055669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Generation of Recombinant Genes in Bacteriophages' [patent_app_type] => utility [patent_app_number] => 11/570608 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10163 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055669.pdf [firstpage_image] =>[orig_patent_app_number] => 11570608 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/570608
Generation of Recombinant Genes in Bacteriophages Jul 5, 2005 Abandoned
Array ( [id] => 7069000 [patent_doc_number] => 20050244383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Method and device for sanitation using bacteriophages' [patent_app_type] => utility [patent_app_number] => 11/173082 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244383.pdf [firstpage_image] =>[orig_patent_app_number] => 11173082 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/173082
Method and device for sanitation using bacteriophages Jun 30, 2005 Abandoned
Array ( [id] => 10892564 [patent_doc_number] => 08916175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection' [patent_app_type] => utility [patent_app_number] => 11/630147 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10572 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11630147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630147
Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection Jun 21, 2005 Issued
Array ( [id] => 6925404 [patent_doc_number] => 20050238659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Vaccine and method of use' [patent_app_type] => utility [patent_app_number] => 11/158652 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10145 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238659.pdf [firstpage_image] =>[orig_patent_app_number] => 11158652 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/158652
Vaccine and method of use Jun 21, 2005 Abandoned
Array ( [id] => 4872759 [patent_doc_number] => 20080199493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors' [patent_app_type] => utility [patent_app_number] => 11/597457 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28086 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199493.pdf [firstpage_image] =>[orig_patent_app_number] => 11597457 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597457
Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors May 24, 2005 Abandoned
Array ( [id] => 5045611 [patent_doc_number] => 20070264284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B' [patent_app_type] => utility [patent_app_number] => 11/597063 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264284.pdf [firstpage_image] =>[orig_patent_app_number] => 11597063 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597063
Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B May 18, 2005 Abandoned
Array ( [id] => 4903922 [patent_doc_number] => 20080113335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods' [patent_app_type] => utility [patent_app_number] => 11/596259 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10523 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113335.pdf [firstpage_image] =>[orig_patent_app_number] => 11596259 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596259
Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods May 9, 2005 Abandoned
Array ( [id] => 7591164 [patent_doc_number] => 07662921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Methods of treating viral disorders' [patent_app_type] => utility [patent_app_number] => 11/578391 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11142 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662921.pdf [firstpage_image] =>[orig_patent_app_number] => 11578391 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578391
Methods of treating viral disorders May 8, 2005 Issued
Array ( [id] => 7216908 [patent_doc_number] => 20050260220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Recombinant therapeutic fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/124971 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5508 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260220.pdf [firstpage_image] =>[orig_patent_app_number] => 11124971 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/124971
Recombinant therapeutic fusion proteins May 8, 2005 Issued
Array ( [id] => 5533038 [patent_doc_number] => 20090232826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2' [patent_app_type] => utility [patent_app_number] => 11/919698 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9867 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232826.pdf [firstpage_image] =>[orig_patent_app_number] => 11919698 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919698
Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 May 1, 2005 Abandoned
Array ( [id] => 7216496 [patent_doc_number] => 20050260168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Compositions comprising viruses and methods for concentrating virus preparations' [patent_app_type] => utility [patent_app_number] => 11/116944 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7814 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260168.pdf [firstpage_image] =>[orig_patent_app_number] => 11116944 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/116944
Compositions comprising viruses and methods for concentrating virus preparations Apr 26, 2005 Abandoned
Array ( [id] => 5130769 [patent_doc_number] => 20070207166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Method of Using Adenoviral Vectors to Induce an Immune Response' [patent_app_type] => utility [patent_app_number] => 11/578096 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24968 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207166.pdf [firstpage_image] =>[orig_patent_app_number] => 11578096 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578096
Method of Using Adenoviral Vectors to Induce an Immune Response Apr 11, 2005 Abandoned
Array ( [id] => 4867440 [patent_doc_number] => 20080146499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12' [patent_app_type] => utility [patent_app_number] => 10/599734 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11287 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146499.pdf [firstpage_image] =>[orig_patent_app_number] => 10599734 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599734
Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 Apr 10, 2005 Abandoned
Array ( [id] => 5794256 [patent_doc_number] => 20060014937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Humanized antibody against S-surface antigen of hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 11/100553 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7005 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014937.pdf [firstpage_image] =>[orig_patent_app_number] => 11100553 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/100553
Humanized antibody against S-surface antigen of hepatitis B virus Apr 6, 2005 Issued
Array ( [id] => 8177622 [patent_doc_number] => 08178657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins' [patent_app_type] => utility [patent_app_number] => 11/547399 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 24056 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178657.pdf [firstpage_image] =>[orig_patent_app_number] => 11547399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547399
Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins Mar 29, 2005 Issued
Menu